The evolution of moral progress and biomedical moral enhancement.

evoliberal evolution moral bioenhancement moral enhancement moral inclusivism moral progress

Journal

Bioethics
ISSN: 1467-8519
Titre abrégé: Bioethics
Pays: England
ID NLM: 8704792

Informations de publication

Date de publication:
09 2019
Historique:
received: 01 08 2018
revised: 08 01 2019
accepted: 23 01 2019
pubmed: 21 5 2019
medline: 15 4 2020
entrez: 21 5 2019
Statut: ppublish

Résumé

In The Evolution of Moral Progress Allen Buchanan and Russell Powell advance an evolutionary explanation of moral progress by morality becoming more 'inclusivist'. We are prepared to accept this explanation as far as it goes, but argue that it fails to explain how morality can become inclusivist in the fuller sense they intend. In fact, it even rules out inclusivism in their intended sense of moral progress, since they believe that human altruism and prosocial attitudes are essentially parochial. We also respond to their charge that the possibility of moral enhancement by biomedical means that we have defended in numerous publications assumes that moral attitudes are biologically hard-wired to an extent that implies that they are resilient to the influence of cognitive or cultural factors. Quite the contrary, we think they are more open to such influence than they seem to do.

Identifiants

pubmed: 31107561
doi: 10.1111/bioe.12592
pmc: PMC6766868
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

814-819

Subventions

Organisme : Wellcome Trust
ID : 104848
Pays : United Kingdom
Organisme : Wellcome Trust
ID : 104848/Z/14/Z
Pays : United Kingdom
Organisme : Wellcome Trust
ID : 203132/Z/16/Z
Pays : United Kingdom

Informations de copyright

© 2019 The Authors Bioethics Published by John Wiley & Sons Ltd.

Références

Bioethics. 2019 Sep;33(7):814-819
pubmed: 31107561

Auteurs

Ingmar Persson (I)

Gothenburg University, Gothenburg, Sweden.
Oxford Uehiro Centre for Practical Ethics, University of Oxford, Oxford, United Kingdom.

Julian Savulescu (J)

Oxford Uehiro Centre for Practical Ethics, University of Oxford, Oxford, United Kingdom.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH